Paul E. Grundy

12.5k total citations · 1 hit paper
139 papers, 7.8k citations indexed

About

Paul E. Grundy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Paul E. Grundy has authored 139 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Molecular Biology, 55 papers in Pulmonary and Respiratory Medicine and 48 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Paul E. Grundy's work include Renal and related cancers (122 papers), Renal cell carcinoma treatment (53 papers) and Ethics and Legal Issues in Pediatric Healthcare (25 papers). Paul E. Grundy is often cited by papers focused on Renal and related cancers (122 papers), Renal cell carcinoma treatment (53 papers) and Ethics and Legal Issues in Pediatric Healthcare (25 papers). Paul E. Grundy collaborates with scholars based in United States, Canada and United Kingdom. Paul E. Grundy's co-authors include Elizabeth J. Perlman, J. Bruce Beckwith, Andrew P. Feinberg, Jeffrey S. Dome, Michael L. Ritchey, N. E. Breslow, Craig J. Dobry, Shirley Rainier, Laura A. Johnson and Norman E. Breslow and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Paul E. Grundy

136 papers receiving 7.6k citations

Hit Papers

Relaxation of imprinted genes in human cancer 1993 2026 2004 2015 1993 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Relaxation of imprinted genes in human cancer
    1993 663 citations Paul E. Grundy, Andrew P. Feinberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul E. Grundy United States 48 6.5k 3.0k 2.4k 1.2k 721 139 7.8k
Jan de Kraker Netherlands 43 3.4k 0.5× 1.9k 0.6× 1.4k 0.6× 362 0.3× 655 0.9× 147 5.6k
James I. Geller United States 35 2.5k 0.4× 1.8k 0.6× 761 0.3× 371 0.3× 792 1.1× 163 4.0k
Max J. Coppes Canada 32 2.4k 0.4× 1.3k 0.4× 931 0.4× 294 0.2× 356 0.5× 122 3.7k
Christophe Bergeron France 44 2.1k 0.3× 2.5k 0.8× 888 0.4× 204 0.2× 1.3k 1.8× 174 5.4k
Masahiro Yao Japan 43 2.9k 0.5× 2.9k 1.0× 455 0.2× 461 0.4× 1.1k 1.5× 269 5.8k
Marcio H. Malogolowkin United States 37 1.8k 0.3× 1.1k 0.4× 753 0.3× 188 0.2× 1.0k 1.4× 124 4.2k
David Y.T. Chen United States 38 3.1k 0.5× 3.6k 1.2× 322 0.1× 290 0.2× 808 1.1× 134 5.3k
Janusz Limon Poland 40 1.8k 0.3× 2.6k 0.8× 207 0.1× 1.2k 1.0× 1.2k 1.6× 240 5.8k
Yukichi Tanaka Japan 31 1.8k 0.3× 1.1k 0.3× 246 0.1× 413 0.3× 977 1.4× 187 4.2k
H. B. Marsden United Kingdom 30 1.5k 0.2× 1.6k 0.5× 727 0.3× 178 0.1× 733 1.0× 93 4.0k

Countries citing papers authored by Paul E. Grundy

Since Specialization
Citations

This map shows the geographic impact of Paul E. Grundy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Grundy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Grundy more than expected).

Fields of papers citing papers by Paul E. Grundy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Grundy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Grundy. The network helps show where Paul E. Grundy may publish in the future.

Co-authorship network of co-authors of Paul E. Grundy

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Grundy. A scholar is included among the top collaborators of Paul E. Grundy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Grundy. Paul E. Grundy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benedetti, Daniel J., Lindsay A. Renfro, Najat C. Daw, et al.. (2024). Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Cancer. 130(13). 2361–2371. 2 indexed citations
2.
Oosterom, Natanja, Saskia L. Gooskens, Lindsay A. Renfro, et al.. (2023). Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy. Journal of Clinical Oncology. 41(26). 4247–4256. 1 indexed citations
3.
Benedetti, Daniel J., Carly R. Varela, Lindsay A. Renfro, et al.. (2023). Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5. Cancer. 130(6). 947–961. 3 indexed citations
4.
Vohra, Sunita, Salima Punja, Hsing Jou, et al.. (2021). Comparative Effectiveness of Pediatric Integrative Medicine: A Pragmatic Cluster-Controlled Trial. Children. 8(4). 311–311. 4 indexed citations
5.
Ehrlich, Peter F., Yueh‐Yun Chi, Murali Chintagumpala, et al.. (2020). Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group. Cancer. 126(15). 3516–3525. 39 indexed citations
6.
Fitch, Margaret I., et al.. (2020). Adolescent and Young Adult Perspectives on Challenges and Improvements to Cancer Survivorship Care: How Are We Doing?. Journal of Adolescent and Young Adult Oncology. 10(4). 432–442. 14 indexed citations
7.
Daw, Najat C., Yueh‐Yun Chi, Yeonil Kim, et al.. (2019). Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study. European Journal of Cancer. 118. 58–66. 23 indexed citations
8.
Fernandez, Conrad V., Elizabeth A. Mullen, Yueh‐Yun Chi, et al.. (2017). Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group Study AREN0532. Journal of Clinical Oncology. 36(3). 254–261. 59 indexed citations
9.
Gratias, Eric J., Jeffrey S. Dome, Lawrence J. Jennings, et al.. (2016). Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group. Journal of Clinical Oncology. 34(26). 3189–3194. 88 indexed citations
10.
11.
Perlman, Elizabeth J., Paul E. Grundy, James R. Anderson, et al.. (2010). WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study. Journal of Clinical Oncology. 29(6). 698–703. 54 indexed citations
12.
Shamberger, Robert C., James R. Anderson, Norman E. Breslow, et al.. (2010). Long-term Outcomes for Infants With Very Low Risk Wilms Tumor Treated With Surgery Alone in National Wilms Tumor Study-5. Annals of Surgery. 251(3). 555–558. 50 indexed citations
13.
Drake, Kylie M., E. Cristy Ruteshouser, Rachael Natrajan, et al.. (2009). Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562. Clinical Cancer Research. 15(19). 5985–5992. 51 indexed citations
14.
Huang, Chiang‐Ching, Samantha Gadd, Norman E. Breslow, et al.. (2009). Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group. Clinical Cancer Research. 15(5). 1770–1778. 43 indexed citations
15.
Niemitz, Emily, Andrew P. Feinberg, Sheri A. Brandenburg, Paul E. Grundy, & Michael R. DeBaun. (2005). Children with Idiopathic Hemihypertrophy and Beckwith-Wiedemann Syndrome Have Different Constitutional Epigenotypes Associated with Wilms Tumor. The American Journal of Human Genetics. 77(5). 887–891. 20 indexed citations
16.
Anglesio, Michael S., Valentina Evdokimova, Nataliya Melnyk, et al.. (2004). Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney. Human Molecular Genetics. 13(18). 2061–2074. 91 indexed citations
17.
Li, Chi-Ming, Connie E. Kim, Jimmy Zhu, et al.. (2004). CTNNB1 Mutations and Overexpression of Wnt/β-Catenin Target Genes in WT1-Mutant Wilms' Tumors. American Journal Of Pathology. 165(6). 1943–1953. 111 indexed citations
18.
Green, D. M., N. E. Breslow, J. Bruce Beckwith, et al.. (1998). Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.. Journal of Clinical Oncology. 16(1). 237–245. 218 indexed citations
19.
Bardeesy, Nabeel, Norma J. Nowak, Bernhard Zabel, et al.. (1994). Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genetics. 7(1). 91–97. 234 indexed citations
20.
Green, Daniel M., et al.. (1991). The role of surgical excision in the management of relapsed Wilms' tumor patients with pulmonary metastases: A report from the National Wilms' Tumor Study. Journal of Pediatric Surgery. 26(6). 728–733. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan de Kraker Breakdown of academic impact, for papers by James I. Geller Breakdown of academic impact, for papers by Max J. Coppes Breakdown of academic impact, for papers by Christophe Bergeron Breakdown of academic impact, for papers by Masahiro Yao Breakdown of academic impact, for papers by Marcio H. Malogolowkin Breakdown of academic impact, for papers by David Y.T. Chen Breakdown of academic impact, for papers by Janusz Limon Breakdown of academic impact, for papers by Yukichi Tanaka Breakdown of academic impact, for papers by H. B. Marsden
Rankless by CCL
2026